para>More morbidity in the elderly, probably owing to decreased lung capacity and likelihood of concomitant diseases
COMPLICATIONS
- Some patients may show evidence of dysfunction in the small airways.
- Delay in treatment of tropical pulmonary eosinophilia may result in irreversible pulmonary fibrosis.
- Steroid complications especially when used long-term such as osteoporosis and increased risk of infections
REFERENCES
11 Fern ¡ndez P ©rez ER, Olson AL, Frankel SK. Eosinophilic lung diseases. Med Clin North Am. 2011;95(6):1163-1187.22 Li H, Groshong SD, Lynch D, et al. Eosinophilic lung disease. Clin Pulm Med. 2010;17(2):66-74.33 Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EPGA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545-553.44 Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002;121(6):1988-1999.55 Philit F, Etienne-Mastro ¯ni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 2002;166(9):1235-1239.66 Jeong YJ, Kim KI, Seo IJ, et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics. 2007;27(3):617-637.77 Furuiye M, Yoshimura N, Kobayashi A, et al. Churg-Strauss syndrome versus chronic eosinophilic pneumonia on high-resolution computed tomographic findings. J Comput Assist Tomogr. 2010;34(1):19-22.88 Marchand E, Reynaud-Gaubert M, Lauque D, et al. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore). 1998;77(5):299-312.99 Rhee CK, Min KH, Yim NY, et al. Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J. 2013;41(2):402-409.1010 Jhun BW, Kim SJ, Son RC, et al. Clinical outcomes in patient with acute eosinophilic pneumonia not treated with corticosteroids. Lung. 2015;193(3):361-367.1111 Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342(11):756-762.1212 Akuthota P, Weller PF. Eosinophilic pneumonias. Clin Microbiol Rev. 2012;25(4):649-660.
ADDITIONAL READING
- Alam M, Burki NK. Chronic eosinophilic pneumonia: a review. South Med J. 2007;100(1):49-53.
- Grau RG. Churg-Strauss syndrome: 2005-2008 update. Curr Rheumatol Rep. 2008;10(6):453-458.
- Janz DR, O'Neal HRJr, Ely EW. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med. 2009;37(4):1470-1474.
- Rossi G, Tironi A, Dore R, et al. Pulmonary eosinophilic infiltrates. Pathologica. 2010;102(6):537-546.
SEE ALSO
Aspergillosis; Roundworms, Tissue; Tuberculosis; Wegener Granulomatosis
CODES
ICD10
J82 Pulmonary eosinophilia, not elsewhere classified
ICD9
518.3 Pulmonary eosinophilia
SNOMED
- Pulmonary eosinophilia (disorder)
- lfflers syndrome (disorder)
- Asthmatic pulmonary eosinophilia (disorder)
CLINICAL PEARLS
- Eosinophilic pneumonias are not common.
- They are classified as either acute or chronic and can be either idiopathic or secondary to other causes.
- Bronchoscopy with bronchoalveolar lavage is useful for diagnosis.
- Corticosteroid therapy is dramatically effective.
- Other treatments are based on secondary etiologies.